8
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Section Review: Oncologic, Endocrine & Metabolic: The vacuolar H+-ATPase: A potential target for drug development in bone diseases

&
Pages 725-740 | Published online: 03 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sanjeev Patel. (1996) Section Review: Oncologic, Endocrine & Metabolic: Drugs in development for the treatment of metabolic bone disease. Expert Opinion on Investigational Drugs 5:4, pages 429-445.
Read now

Articles from other publishers (6)

Bhavneet K. Chawla, Robert E. Cohen, Elizabeth M. Stellrecht & Lisa M. Yerke. (2022) The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review. Clinical and Experimental Dental Research 8:5, pages 1045-1058.
Crossref
M. J. Rogers. (2004) From Molds and Macrophages to Mevalonate: A Decade of Progress in Understanding the Molecular Mode of Action of Bisphosphonates. Calcified Tissue International 75:6, pages 451-461.
Crossref
Michael J. Rogers, S. Gordon, H. L. Benford, F. P. Coxon, S. P. Luckman, J. Monkkonen & J. C. Frith. (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:S12, pages 2961-2978.
Crossref
M. Amling, A. F. Schilling & J. M. Rueger. 2000. Zelluläre Interaktion mit Biomaterialien. Zelluläre Interaktion mit Biomaterialien 43 61 .
Stefania Gagliardi, P. Andrea Gatti, Pietro Belfiore, Andrea Zocchetti, Geoffrey D. Clarke & Carlo Farina. (1998) Synthesis and Structure−Activity Relationships of Bafilomycin A 1 Derivatives as Inhibitors of Vacuolar H + -ATPase . Journal of Medicinal Chemistry 41:11, pages 1883-1893.
Crossref
S Patel. (1996) Current and potential future drug treatments for osteoporosis.. Annals of the Rheumatic Diseases 55:10, pages 700-714.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.